BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1625618)

  • 1. South Australian hypertension survey. General practitioner experiences with drug treatment.
    Steven ID; Wilson DH; Wakefield MA; Beilby J; Coffey GA; Esterman AJ; Golding AP; Graham NM; Litt JC; Rohrsheim RA
    Med J Aust; 1992 May; 156(9):641-4. PubMed ID: 1625618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. South Australian hypertension survey. General practitioner knowledge and reported management practices--a cause for concern?
    Steven ID; Wilson DH; Wakefield MA; Beilby J; Coffey GA; Esterman AJ; Golding AP; Graham NM; Litt JC; Rohrsheim RA
    Med J Aust; 1992 Mar; 156(6):423-8. PubMed ID: 1545751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice.
    Jafar TH; Jessani S; Jafary FH; Ishaq M; Orakzai R; Orakzai S; Levey AS; Chaturvedi N
    Circulation; 2005 Mar; 111(10):1278-83. PubMed ID: 15769769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia.
    Burge F; Kephart G; Flowerdew G; Putnam W; Comeau DG; Whelan AM; Sketris I; Sclar D
    Can J Clin Pharmacol; 2001; 8(3):139-45. PubMed ID: 11574896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in antihypertensive drug therapy in general practice: results from a random national survey.
    Kawachi I; Malcolm LA; Purdie G
    N Z Med J; 1989 Jun; 102(870):307-9. PubMed ID: 2567977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO; Okubadejo NU
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive prescribing--a survey of general practice supervisors and registrars.
    Eastman P
    Aust Fam Physician; 2008 Nov; 37(11):969-71. PubMed ID: 19037476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns and cost of antihypertensive drugs in an internal medicine clinic.
    Jhaj R; Goel NK; Gautam CS; Hota D; Sangeeta B; Sood A; Sachdev A
    Indian Heart J; 2001; 53(3):323-7. PubMed ID: 11516032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment patterns of hypertension in 1996. Data from the Quebec Family Practice, University of Sherbrooke registry].
    Laplante P; Niyonsenga T; Delisle E; Vanasse N; Vanasse A; Grant AM; Xhignesse M
    Can Fam Physician; 1998 Feb; 44():306-12. PubMed ID: 9512834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretics for hypertension--an inconsistency in primary care prescribing behaviour.
    Kuehlein T; Laux G; Gutscher A; Goetz K; Szecsenyi J; Campbell S; Steinhaeuser J
    Curr Med Res Opin; 2011 Mar; 27(3):497-502. PubMed ID: 21208153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of drug cost on hypertension treatment decision.
    Salman H; Bergman M; Hart J; Neuman V; Zevin D; Bessler H; Djaldetti M
    Public Health; 1999 Sep; 113(5):243-6. PubMed ID: 10557119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the use of a spironolactone and angiotensin-converting enzyme inhibitor combination: a population-based analysis.
    Besançon JF; Lagarce L; Diquet B; Lainé-Cessac P
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):172-9. PubMed ID: 17948926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA; Sequeira RP
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.